BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,412,000 | +11.7% | 1,073,000 | -10.0% | 0.18% | -8.8% |
| Q1 2020 | $1,264,000 | -4.5% | 1,192,000 | -2.1% | 0.19% | +23.7% |
| Q4 2019 | $1,323,000 | +3.1% | 1,217,000 | -1.9% | 0.16% | -9.3% |
| Q3 2019 | $1,283,000 | -9.8% | 1,240,000 | -1.8% | 0.17% | -10.4% |
| Q2 2019 | $1,422,000 | -4.2% | 1,263,000 | -3.2% | 0.19% | -9.4% |
| Q1 2019 | $1,485,000 | -2.8% | 1,305,000 | -4.7% | 0.21% | -7.8% |
| Q4 2018 | $1,528,000 | +51.4% | 1,370,000 | +63.1% | 0.23% | +82.5% |
| Q3 2018 | $1,009,000 | +9.7% | 840,000 | +8.2% | 0.13% | +9.6% |
| Q2 2018 | $920,000 | +5.1% | 776,000 | -1.6% | 0.12% | +4.5% |
| Q1 2018 | $875,000 | +5.5% | 789,000 | +13.0% | 0.11% | +1.9% |
| Q4 2017 | $829,000 | +2268.6% | 698,000 | +2306.9% | 0.11% | +2060.0% |
| Q3 2017 | $35,000 | 0.0% | 29,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $35,000 | -10.3% | 29,000 | -12.1% | 0.01% | -16.7% |
| Q1 2017 | $39,000 | -25.0% | 33,000 | -25.0% | 0.01% | -25.0% |
| Q4 2016 | $52,000 | -5.5% | 44,000 | 0.0% | 0.01% | -11.1% |
| Q3 2016 | $55,000 | -65.4% | 44,000 | -67.9% | 0.01% | -67.9% |
| Q2 2016 | $159,000 | -72.4% | 137,000 | -71.8% | 0.03% | -74.8% |
| Q1 2016 | $576,000 | -13.5% | 485,000 | -2.2% | 0.11% | -16.5% |
| Q4 2015 | $666,000 | -4.0% | 496,000 | -3.3% | 0.13% | -20.4% |
| Q3 2015 | $694,000 | -17.2% | 513,000 | +97800.8% | 0.17% | -15.7% |
| Q2 2015 | $838,000 | +0.1% | 524 | -99.9% | 0.20% | -5.3% |
| Q1 2015 | $837,000 | +21.0% | 553,000 | +97430.9% | 0.21% | +5.0% |
| Q4 2014 | $692,000 | +7.3% | 567 | -99.9% | 0.20% | +7.0% |
| Q3 2014 | $645,000 | +1.3% | 584,000 | -3.5% | 0.19% | +2.2% |
| Q2 2014 | $637,000 | +1.0% | 605,000 | +6.5% | 0.18% | -2.7% |
| Q1 2014 | $631,000 | -1.1% | 568,000 | -3.9% | 0.19% | -4.6% |
| Q4 2013 | $638,000 | – | 591,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |